Related Experiment Video

Updated: Aug 26, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Pulmonary sarcoidosis: new genetic clues and ongoing treatment controversies

Daniel A Culver1, Mary Jane Thomassen, Mani S Kavuru

  • 1Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, OH 44195, USA.

Cleveland Clinic Journal of Medicine
|February 26, 2004
PubMed

Insights

Sarcoidosis presents complex, multisystemic challenges. Research is advancing understanding of its genetic basis and optimizing corticosteroid treatment strategies.

Area of Science:

  • Immunology
  • Genetics
  • Pulmonology

Background:

  • Sarcoidosis is a multisystemic inflammatory disease with diverse clinical presentations.
  • Diagnosis and management of sarcoidosis are often complicated by its wide-ranging manifestations.
  • Current treatment guidelines for sarcoidosis, particularly regarding corticosteroids, lack definitive consensus.

Purpose of the Study:

  • To review the current understanding of sarcoidosis.
  • To discuss the complexities in diagnosing and managing sarcoidosis.
  • To highlight the ongoing research into the genetic underpinnings and therapeutic approaches for sarcoidosis.

Main Methods:

  • Literature review of sarcoidosis diagnosis and management.
  • Analysis of current corticosteroid treatment controversies.
  • Summary of emerging research on the genetic basis of sarcoidosis.

Main Results:

  • Sarcoidosis diagnosis and management are challenging due to its multisystemic nature.
  • Corticosteroid therapy is effective but debated regarding optimal initiation, dosage, and duration.
  • The genetic basis of sarcoidosis is an area of active and developing research.

Conclusions:

  • Further research is needed to clarify optimal corticosteroid treatment protocols for sarcoidosis.
  • Understanding the genetic factors influencing sarcoidosis development is crucial for future therapeutic advancements.
  • Multidisciplinary approaches are essential for effectively managing patients with sarcoidosis.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...